OOIR: Observatory of International Research

Papers

(The H4-Index of European Neuropsychopharmacology is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
T58. EXPLORATION OF GENETIC AND CLINICAL HETEROGENEITY IN AUTISM BY CLUSTERING GENES BASED ON BULK AND SINGLE-CELL TRANSCRIPTOMIC DATA	402
11. ESTABLISHING THE MOLECULAR FOUNDATION OF BRAIN ANATOMY IN LIVING INDIVIDUALS	112
T47. A MULTI-OMIC QTL ANALYSIS OF MAJOR DEPRESSIVE DISORDER	106
T84. AN INVESTIGATION ON GENETIC MECHANISMS UNDER CLINICAL HETEROGENEITY IN SCHIZOPHRENIA	102
F41. AMBER: ANTIDEPRESSANT MEDICATIONS: BIOLOGY, EXPOSURE AND RESPONSE	101
T56. DIP2A, HIGHLY EXPRESSED GENE IN THE CEREBELLUM, IS ASSOCIATED WITH A WIDE RANGE OF PSYCHIATRIC SYMPTOMS (DELAYED SPEECH, AUTISM SPECTRUM DISORDER AND SPECIFIC LEARNING DISABILITIES)	87
T13. GENETIC ASSOCIATIONS OF ICD-DERIVED PSYCHIATRIC DIAGNOSES WITH SELF-REPORTED MENTAL HEALTH PHENOTYPES IN THE UK BIOBANK	74
F8. THE DEVELOPMENTAL LANDSCAPE OF NEUROPSYCHIATRIC GENOMICS IN AFRICA	73
T78. GENE-ENVIRONMENT INTERACTION STUDY ON THE CORRELATES FOR PSYCHOTIC EXPERIENCES IN THE UK BIOBANK	67
T100. CHILD SUBCORTICAL BRAIN VOLUMES: THE INTERACTION BETWEEN GENETIC RISK AND MATERNAL PSYCHOLOGICAL DISTRESS DURING PREGNANCY	66
F97. DIFFERENTIAL EXPRESSION OF MICRORNAS UPON IN VITRO LITHIUM AND VALPROATE EXPOSURE TO BIPOLAR DISORDER PATIENTS-DERIVED LCLS	65
41. CHARACTERIZING FUNCTIONAL CONVERGENCE OF COMMON POLYGENIC VARIATION IN NEUROPSYCHIATRIC DISORDER RISK GENES	65
F75. PREDICTION OF TREATMENT-RESISTANT SCHIZOPHRENIA USING REAL-WORLD DATA AND MULTIMODAL ANALYTICAL TOOLS	65
85. DETECTION OF PLACENTAL SCHIZOPHRENIA RISK GENES	62
1. DEVELOPMENTAL TRAJECTORIES OF DNA METHYLATION IN NEURAL CELL POPULATIONS IN HUMAN CORTEX AND LINKS TO NEURODEVELOPMENTAL DISORDERS	61
2. ENRICHMENT OF RARE, DAMAGING VARIANTS IN SCHIZOPHRENIA-RELATED GENES IN INTELLECTUAL DISABILITY PATIENTS WITH PSYCHOTIC DISORDERS	54
T33. USING GENOMICS TO AID EARLY DIFFERENTIAL DIAGNOSIS BETWEEN BIPOLAR DISORDER AND MAJOR DEPRESSION	52
T35. SHARED GENETIC LIABILITY FOR ALCOHOL CONSUMPTION, ALCOHOL PROBLEMS, AND SUICIDAL BEHAVIOR: EVALUATING THE ROLE OF IMPULSIVITY	52
T67. ASSOCIATIONS BETWEEN METHYLATION AGE AND BRAIN AGE IN LATE ADOLESCENCE	50
T59. A GENOME-WIDE ASSOCIATION STUDY OF EATING DISORDER SYMPTOMS BASED ON THE SCOFF QUESTIONNAIRE	50
6. DE NOVO MUTATIONS IN BIPOLAR DISORDER IMPLICATE GENES INVOLVED IN NEURODEVELOPMENT AND IMMUNITY	46
F48. INVESTIGATING POTENTIAL RELATIONSHIPS BETWEEN PIGMENTATION GENETICS AND PARKINSON'S DISEASE (PD)	45
Society Calendar	44
W101. EPIGENETIC PROFILES OF LATENT CLASSES FOR POLYSUBSTANCE USE DISORDER	44
HOW PARTICIPATING IN CAMH'S PHARMACOGENETICS IMPACT STUDY CHANGED MY LIFE	43

F7. THE ASSOCIATIONS BETWEEN EDUCATIONAL EXPERIENCES AND MENTAL HEALTH FROM CHILDHOOD TO YOUNG ADULTHOOD	41
W64. FAMILY BASED ASSOCIATION AND LINKAGE ANALYSES OF FAMILIAL ADHD	40
POLYGENIC RISK SCORES FOR PROBLEMATIC SUBSTANCE USE IN ADOLESCENTS: AN ENIGMA-ADDICTION STUDY	38
Comparative effectiveness of mood stabilizers and antipsychotics in the prevention of hospitalization after lithium discontinuation in bipolar disorder	37
8. A CROSS-POPULATION GENOME-WIDE ASSOCIATION STUDY OF SLEEP DURATION	36
DECOLONISATION OF PSYCHIATRIC GENETICS: PERSPECTIVES FROM AN ERSTWHILE “JEWEL IN THE CROWN” COLONY	35
NOVEL LOCI AND TARGET GENES INFLUENCING FUNCTIONAL SEIZURES IDENTIFIED IN A MULTI-SITE GENOME-WIDE ASSOCIATION STUDY META-ANALYSIS IN A SAMPLE OF 570,460 PATIENTS	34
THE ASSOCIATION BETWEEN POLYGENIC RISK FOR SCHIZOPHRENIA AND BRAIN AGE IN A POPULATION-BASED SAMPLE OF YOUNG ADULTS: A RECALL-BY-GENOTYPE-BASED APPROACH	34
The association of CNR1 genetic variants with resting-state functional connectivity in youth bipolar disorder	33
GENETIC COUNSELING FOR PSYCHIATRIC CONDITIONS	33
Editorial Board	33
DO POOR DIET AND LIFESTYLE BEHAVIOURS EXACERBATE THE GENETIC RISK OF IMPULSIVITY IN THE GENERAL POPULATION	33